SIGNAL TRANSDUCTION IN B CELL ACTIVATION
SIGNAL TRANSDUCTION IN B CELL ACTIVATION
批准号:
3132104
负责人:
John C Cambier
金额:
$21.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-12-01 至 1996-05-31
关键词:
B cell receptor B lymphocyte anergy antireceptor antibody biological signal transduction calcium flux cytoskeleton hamsters immunoglobulins laboratory mouse laboratory rabbit leukocyte activation /transformation membrane proteins molecular cloning phosphoproteins phosphorylation protein structure function protein tyrosine kinase receptor expression tissue /cell culture transfection
中文摘要
B淋巴细胞抗原受体,膜免疫球蛋白(mIg),在
英文摘要
B lymphocyte antigen receptors, membrane immunoglobulins (mIg), function in
transduction of information across the plasma membrane leading to altered
gene expression and cell activation, and in focussing and internalization
of antigen for subsequent processing and presentation to T cells. Recent
findings indicate that under certain circumstances ligation of membrane
immunoglobulin also leads to inactivation of the ability of the cell's
unligated receptors to transduce signals. This "desensitization" may be
the basis of tolerance mediated by clonal anergy in the B cell pool. The
performance of all of these functions requires that mIg molecules
communicate physically with molecules in the cytoplasm. This protein, or
could be indirect, involving secondary membrane proteins which bridge
receptor mIg with cytosolic protein, or could be indirect, occurring via
interaction of the cytoplasmic tail of mIg with cytosolic protein, or could
be indirect, involving secondary membrane proteins which bridge receptor
mIg to cytosolic proteins. The lack of significant cytoplasmic structure
in mIg molecules virtually excludes the former possibility and, until
recently, only fragmentary data existed in support of the latter
possibility. We have found that membrane immunoglobulins are noncovalently
associated with a complex of proteins composed of two disulfide bonded
heterodimers and that components of these complexes differ slightly between
mIgM-associated and mIgD-associated forms. mIgM is associated with
heterodimers of IgMalpha(32kDa) and Igbeta(37kDa), and IgMalpha and Iggamma
(34kDa) proteins. mIgD is associated with heterodimers of IgDalpha
(33kDa), and Igbeta, and IgDalpha and Iggamma proteins. Recent studies
indicate that IgMalpha and IgDalpha are products of the mb-1 gene(s), and
that Igbeta and Igalpha are products of the B29 gene(s). Distinct alpha
subunit usage may determine the previously noted differences in biological
responses which follow mIgM vs. mIgD ligation. Consistent with a role in
signal transduction and receptor desensitization, multiple subunits of the
above complex are inducibly phosphorylated on tyrosine residues.
In this application, we propose to determine the function of these proteins
and specific structural motifs which they exhibit, in mediating receptor
function. These studies will involve the cloning of IgMalpha, IgDalpha,
Igbeta and Iggamma encoding proteins of the genes. Based on deduced
sequence, we will produce antibodies specific for subunits of the complex
and use these antibodies to study subunit distribution and function. We
will utilize biochemical approaches to identify specific sites
phosphorylated during signal transduction, desensitization, and
cytoskeletal interaction. We will determine the role of specific
phosphorylation events in receptor function by production and analysis of
transfected B cell which express mutant receptor subunits in which specific
phosphorylation sites are altered or absent. The proposed studies should
contribute significantly to our understanding of the molecular basis of B
lymphocyte activation, antigen processing and tolerance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autoimmunity risk alleles compromising B cell anergy
-
批准号:9568080
-
项目类别:
-
资助金额:$11.26万
-
财政年份:2016
-
负责人:John C Cambier
-
依托单位:
Autoimmunity risk alleles compromising B cell anergy
-
批准号:9121221
-
项目类别:
-
资助金额:$45.51万
-
财政年份:2016
-
负责人:John C Cambier
-
依托单位:
Insulin Specific T and B cells in Type 1 Diabetes
-
批准号:9180031
-
项目类别:
-
资助金额:$168.89万
-
财政年份:2016
-
负责人:John C Cambier
-
依托单位:
Perturbation of B cell anergy in T1D
-
批准号:9225164
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2016
-
负责人:John C Cambier
-
依托单位:
Perturbation of B cell anergy in T1D
-
批准号:9121223
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2016
-
负责人:John C Cambier
-
依托单位:
B Cells and Type 1 Diabetes
-
批准号:8372067
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2012
-
负责人:John C Cambier
-
依托单位:
B Cells and Type 1 Diabetes
-
批准号:9104150
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2012
-
负责人:John C Cambier
-
依托单位:
Mouse modeling of a human STING gene variant for infectious disease
-
批准号:8282484
-
项目类别:
-
资助金额:$19.26万
-
财政年份:2012
-
负责人:John C Cambier
-
依托单位:
B Cells and Type 1 Diabetes
-
批准号:8690052
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2012
-
负责人:John C Cambier
-
依托单位:
Mouse modeling of a human STING gene variant for infectious disease
-
批准号:8519291
-
项目类别:
-
资助金额:$21.79万
-
财政年份:2012
-
负责人:John C Cambier
-
依托单位:
B Cells and Type 1 Diabetes
-
批准号:8534115
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2012
-
负责人:John C Cambier
-
依托单位:
Flow Cytometry
-
批准号:8311794
-
项目类别:
-
资助金额:$11.73万
-
财政年份:2011
-
负责人:John C Cambier
-
依托单位:
Maintenance of B Cell Anergy
-
批准号:8311792
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2011
-
负责人:John C Cambier
-
依托单位:
Molecular Mechanisms of Immune Tolerance
-
批准号:8468627
-
项目类别:
-
资助金额:$22.53万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
Infectious Agents and B Cell Anergy
-
批准号:8188300
-
项目类别:
-
资助金额:$37.87万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
Infectious Agents and B Cell Anergy
-
批准号:8580189
-
项目类别:
-
资助金额:$37.87万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
B Cell Development in Aging
-
批准号:7879507
-
项目类别:
-
资助金额:$18.93万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
Molecular Mechanisms of Immune Tolerance
-
批准号:9804163
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
Molecular Mechanisms of Immune Tolerance
-
批准号:7893587
-
项目类别:
-
资助金额:$21.65万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
Molecular Mechanisms of Immune Tolerance
-
批准号:8055949
-
项目类别:
-
资助金额:$21.4万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
海外基金